两种核苷类药物治疗慢性乙型肝炎的疗效及经济学分析(1)
 |
| 第1页 |
参见附件。
【摘要】目的:对比拉米夫定与替比夫定治疗慢性乙肝的疗效及经济效果。方法:将93例患者随机分为2组。一组应用拉米夫定治疗(48例),另一组替比夫定治疗(45例)。统计分析两组的疗效并进行经济学分析。结果与结论:两组药物均能有效治疗慢性乙肝,替比夫定效果较好。两种药物在药物经济学方面无显著性差异。
【关键词】替比夫定;拉米夫定;慢性乙肝;药学经济学
pharmacoeconomic analysis of two different nucleoside drugs for chronic hepatitis B
He Wen
【Abstract】Objective:To compare the effect and economic effectiveness of lamivudine and telbivudine in treating chronic hepatitis B. Methods:93 patients with impotence were divided into two groups. The patients in the first group (48) were treated with lamivudine. The patients in the second group (45) were treated with telbivudine. Results & ConclusionL:Both therapeutic schemes were effective in treating chronic hepatitis B. telbivudine was slightly better. There was no significant difference in the pharmacoeconomic between the two groups ......
您现在查看是摘要介绍页，详见PDF附件。